Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Potential Beneficial Effects of Resveratrol on Obesity, Metabolic Syndrome and Inflammation - Emphasis on Description of the Molecular Biology Underpinning the Interplay Between Calorie Restriction, SIRT1, STAT5 and the GH/IGF-I Axis

Authors not listed

University of Aarhus · 2010

Abstract

We want to investigate whether the food supplement resveratrol is able to counteract the detrimental effects of obesity.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-13 MST

Cite this

APA
Anonymous. (2010). Potential Beneficial Effects of Resveratrol on Obesity, Metabolic Syndrome and Inflammation - Emphasis on Description of the Molecular Biology Underpinning the Interplay Between Calorie Restriction, SIRT1, STAT5 and the GH/IGF-I Axis. <em>University of Aarhus</em>. https://clinicaltrials.gov/study/NCT01150955
Vancouver
Anonymous. Potential Beneficial Effects of Resveratrol on Obesity, Metabolic Syndrome and Inflammation - Emphasis on Description of the Molecular Biology Underpinning the Interplay Between Calorie Restriction, SIRT1, STAT5 and the GH/IGF-I Axis. University of Aarhus. 2010.
BibTeX
@misc{anon2010Potent, title = {Potential Beneficial Effects of Resveratrol on Obesity, Metabolic Syndrome and Inflammation - Emphasis on Description of the Molecular Biology Underpinning the Interplay Between Calorie Restriction, SIRT1, STAT5 and the GH/IGF-I Axis}, author = {Anonymous}, journal = {University of Aarhus}, year = {2010}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020
Open access · OA

Diabetic fibrosis

▲ 213